Shows
The Verisian Community PodcastThe Birth of the CRO Industry: How Parexel Transformed Drug Development | Episode 16Description
Josef von Rickenbach is a true pioneer in the pharmaceutical industry. In 1982, he co-founded Parexel, a company that would go on to define the CRO industry as we know it today. Over the next 36 years as CEO, he led over 40 acquisitions, scaled the company to 19,000 employees, and helped set industry standards that still shape biopharma today.
But Josef’s story isn’t just about business. It’s a story of relentless execution, risk-taking, and building an entirely new industry from scratch. Convincing pharma companies to outsource clinical research - an idea that was unheard of at...2025-03-071h 26The Verisian Community PodcastThe End of Double Programming? | Episode 15Episode Summary
Double programming has long been the industry standard for validation in statistical programming, but is it the most effective approach? In this episode, Henning Kuich, Richardus Vonk, Sunil Gupta and Tomás Sabat Stöfsel discuss how code traceability is transforming the validation process, enhancing transparency, improving efficiency, reducing costs and enabling better collaboration across teams.
The conversation explores the limitations of traditional validation methods, the potential of modern technology to streamline workflows, and the implications for the future of statistical programming. Watch now to learn about the evolution of validation and th...2025-02-221h 11The Verisian Community PodcastThe Future of R in Clinical Programming | Episode 14Episode Summary
In this episode, we sit down with David, an expert in R programming for clinical trials, to discuss the evolving landscape of statistical programming. From his unconventional journey from journalism and philosophy into programming to his deep insights on the maintainability and stability of R in the pharmaceutical industry, David shares his perspective on the challenges and opportunities of open-source programming. He explores the key differences between R and SAS, the critical importance of backward compatibility, and how organizations can future-proof their R-based systems. David also introduces his work on PackageDiff, a tool aimed...2025-02-0330 minThe Verisian Community PodcastOpen Source and OpenStudyBuilder | Episode 13Episode Summary
In this episode of the Verisian Community Podcast, Katja explores the huge potential of open-source tools in clinical development. She discusses how platforms like OpenStudyBuilder are revolutionizing study design and collaboration within the pharma industry. Katja shares her experiences in overcoming resistance to open-source adoption, addressing challenges like regulatory constraints and industry skepticism. The conversation delves into the evolving role of traditional tools like SAS alongside modern languages such as R and Python. Katja closes with a forward-looking vision for how open-source technology can reshape the future of clinical development and regulatory submissions over...2024-12-2028 minThe Verisian Community PodcastAutomation and AI in Clinical Trial Reporting | Episode 12Episode Summary
In this episode, Shafi discusses his decades-long journey and what led him into the world of statistical programming. He shares insights into the evolution of automation in clinical trials, its role in transforming traditional tasks like validation and double programming, and the impact AI is having on oversight and traceability for large teams. Shafi also addresses the ongoing challenges in scaling AI for clinical trial reporting and how embracing these technologies is critical for staying ahead in the evolving landscape of the industry.
Biography Shafi
Shafi has been a programmer...2024-10-0842 minThe Verisian Community PodcastThe Future of Clinical Trials | Episode 11Episode Summary
In this episode, Nijat from Lindus Health shares their vision for building the future of clinical trials by creating what they call the "anti-CRO." He dives into Lindus Health's mission and his personal passion for driving change in this space. Nijat explores the challenges of innovation in clinical trials, particularly the complexity of aligning trials with patient needs while navigating the demands of various stakeholders. Nijat sheds light on how Lindus Health is addressing these challenges and redefining the clinical trial process to better serve patients and the industry alike.
Biography Nijat...2024-09-2132 minThe Verisian Community PodcastMastering Statistical Programming: Journey, Skills, Challenges, and Future Insights | Episode 10Episode Summary
In this episode of the Verisian Community Podcast, we welcome Sunil Kumar Pusarla to share his journey and insights from over 20 years in statistical programming. Sunil discusses the skills and traits essential for success as a statistical programmer, addressing the challenges and pressures that professionals face today. He emphasizes the importance of maintaining high-quality standards, even under tight deadlines, and compares the distinct cultures and expectations of big pharma versus smaller biotech companies. Sunil also explores how technological advancements are reshaping the role of statistical programmers and offers his vision for how the field will...2024-09-1034 minThe Verisian Community PodcastTactical and Strategic Use of AI in the Planning, Evaluation, and Reporting of Clinical TrialsEpisode Summary
In this episode of the Verisian Community Podcast, Richardus Vonk discusses the transformative role of AI in clinical trials. He explores how AI is reshaping trial planning and execution, improving early disease detection like cancer, and the challenges it still faces in drug development. Richardus also highlights the benefits of automation in freeing up time for deeper scientific exploration and elaborates on the tactical versus strategic use of AI and GenAI. The conversation touches on the rise of open-source tools, balancing data sharing with patient privacy, while offering a vision for the future of clinical...2024-08-3130 minThe Verisian Community PodcastThe Limitations and Opportunities of Large Language ModelsEpisode Summary
In this episode of the Verisian Community Podcast, we welcome Ricardo Baeza-Yates, a renowned computer scientist, to discuss the world of Large Language Models (LLMs) and their implications. Ricardo delves into the mechanics of LLMs, their popularity, and the challenges they pose. He discusses the inherent lack of reasoning and understanding in LLMs, explores the limitations in reproducibility, and emphasizes the importance of transparency in AI development. Ricardo shares his insights on how these issues impact the reliability and application of LLMs, particularly in contexts requiring precision and trustworthiness.
Resources
China AI...2024-08-2341 minThe Verisian Community PodcastNavigating Challenges and Unlocking Opportunities as a Statistical ProgrammerEpisode Summary
In this episode of the Verisian Community Podcast, we welcome Daniel Rolo, Director of Statistical Programming at Parexel to discuss the evolving landscape of statistical programming. Daniel addresses the shift from traditional tools like SAS to modern languages such as Python and R, emphasizing the response to increasing data complexity and the rise of open-source platforms and AI. He outlines the challenges programmers face when adapting to these new tools and provides strategies for effective learning and professional growth. The conversation also covers the importance of staying updated with changing clinical data standards and how...2024-04-2334 minThe Verisian Community PodcastThe New Age Statistical ProgrammerEpisode Summary
In this Verisian Community Podcast episode, we welcome Ritika Aggarwal from Novartis, who shares insights on the evolving landscape of statistical programming. Addressing challenges like data complexity and the rise of AI, Ritika frames these as opportunities for innovation. We touch on the industry's adaptation to the "new normal," the crucial role of continuous learning for programmers, and the importance of staying updated with changing clinical data standards. Ritika's experiences offer a deep dive into the dynamic field of statistical programming, highlighting the potential for professional growth and the overall advancement of the industry.
2024-03-1435 minThe Verisian Community PodcastGood Programming Practice in Clinical Programming IIEpisode Summary
In this episode of the Verisian Community Podcast, we're thrilled to welcome Mansi Thakrar, a Statistical Programmer at Massachusetts General Hospital. This marks our second installment dedicated to discussing good programming practices, where Mansi shares her insights into what constitutes good statistical code in biostatistics. Additionally, we delve into the challenges and opportunities presented by AI in clinical programming, and Mansi provides practical tips tailored for new statistical programmers.
Resources
Learn more about us: https://www.verisian.com/
Join the Verisian Community: https://www.verisian.com/community
Follow us on LinkedIn...2024-03-1427 minThe Verisian Community PodcastAutomation, Generative AI, and Success in Statistical ProgrammingEpisode Summary
In this episode of the Verisian Community Podcast, we welcome Shadab from Merck and Rahul from Johnson & Johnson. Our conversation begins with a discussion on the feasibility and desirability of achieving end-to-end automation in the realm of clinical programming. We then delve into the world of generative AI, exploring its potential to revolutionize existing workflows. To wrap up, we discuss the evolving skill set and qualifications necessary to excel as a statistical programmer in today's dynamic industry.
Resources
Learn more about us: https://www.verisian.com/
Join the Verisian Community: https://www...2024-01-0441 minThe Verisian Community PodcastGood Programming Practice in Clinical ProgrammingEpisode Summary
In this episode of the Verisian Community Podcast, we welcome Cornelia from Bayer, to discuss good programming practice in clinical programming. Cornelia highlights the critical aspects of writing good SAS code and adapting to languages such as R. Cornelia delves into how Bayer is embracing AI in clinical programming and emphasizes the pivotal role of maintaining high standards in code quality and thorough documentation, especially for regulatory compliance.
Resources
Learn more about us: https://www.verisian.com/
Join the Verisian Community: https://www.verisian.com/community
Follow us on LinkedIn: https://www...2023-12-2326 minThe Verisian Community PodcastOpen Source in Clinical Analysis: Challenges, OpportunitiesEpisode Summary
In this episode of the Verisian Community Podcast, Kyle (Syneos) and Oliver (Bayer) discuss the challenges and opportunities of open source in clinical analysis. They look at the importance of people and communication within the industry and the need for a culture change before embracing new systems. They also explore the potential of AI in clinical analysis, highlighting its benefits in code generation and documentation. They agree the need for validation and trust in AI systems and the importance of human expertise in tying everything together.
Resources
Learn more about us...2023-12-1136 minThe Verisian Community PodcastInaugural Podcast: Validation in Clinical ProgrammingEpisode Summary
In the first episode of the Verisian Community Podcast, Tomás and Henning, along with industry expert Sunil, discuss how new technology can improve the world of statistical programming. They look at how the Verisian Validation Engine ensures programmers can guarantee the integrity of their analyses. The discussion navigates through the evolution of data analytics cas, the potential of AI in clinical programming, and previews Verisian's forward-looking initiatives in clinical reporting.
Resources
Learn more about us: https://www.verisian.com/
Join the Verisian Community: https://www.verisian.com/community
Follow us on...2023-12-0247 min